Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics & Policy

FDA: Competition slowing for first-in-class drugs

Steve Usdin
July 25, 2018 2:05 PM UTC

First-in-class drugs are facing less competition today than they did in the past, according to a new analysis conducted by FDA.

FDA Commissioner Scott Gottlieb described the analysis to a congressional committee Wednesday, and said FDA plans to issue guidance on seamless clinical trials that could speed the entry of competing drugs with the same mechanism of action as first-in-class therapies...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

U.S. Food and Drug Administration (FDA)